421 related articles for article (PubMed ID: 32023511)
1. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
[TBL] [Abstract][Full Text] [Related]
2. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
3. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.
Tambe P; Kumar P; Paknikar KM; Gajbhiye V
Int J Nanomedicine; 2018; 13():7669-7680. PubMed ID: 30538451
[TBL] [Abstract][Full Text] [Related]
4. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB).
Arulmozhi V; Pandian K; Mirunalini S
Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810
[TBL] [Abstract][Full Text] [Related]
5. Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy.
Wang B; Zhang K; Wang J; Zhao R; Zhang Q; Kong X
Colloids Surf B Biointerfaces; 2020 May; 189():110832. PubMed ID: 32070865
[TBL] [Abstract][Full Text] [Related]
6. Enhanced efficacy and drug delivery with lipid coated mesoporous silica nanoparticles in cancer therapy.
Amin MU; Ali S; Ali MY; Tariq I; Nasrullah U; Pinnapreddy SR; Wölk C; Bakowsky U; Brüßler J
Eur J Pharm Biopharm; 2021 Aug; 165():31-40. PubMed ID: 33962002
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial and anticancer activities of asymmetric lollipop-like mesoporous silica nanoparticles loaded with curcumin and gentamicin sulfate.
Cheng Y; Zhang Y; Deng W; Hu J
Colloids Surf B Biointerfaces; 2020 Feb; 186():110744. PubMed ID: 31874345
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of acetylated carboxymethylcellulose coated hollow mesoporous silica hybrid nanoparticles for nucleolin targeted delivery to colon adenocarcinoma.
Nejabat M; Mohammadi M; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Carbohydr Polym; 2018 Oct; 197():157-166. PubMed ID: 30007600
[TBL] [Abstract][Full Text] [Related]
11. Engineering Mesoporous Silica Nanoparticles for Targeted Alpha Therapy against Breast Cancer.
Pallares RM; Agbo P; Liu X; An DD; Gauny SS; Zeltmann SE; Minor AM; Abergel RJ
ACS Appl Mater Interfaces; 2020 Sep; 12(36):40078-40084. PubMed ID: 32805833
[TBL] [Abstract][Full Text] [Related]
12. Carboxylated chitosan-mediated improved efficacy of mesoporous silica nanoparticle-based targeted drug delivery system for breast cancer therapy.
Lohiya G; Katti DS
Carbohydr Polym; 2022 Feb; 277():118822. PubMed ID: 34893239
[TBL] [Abstract][Full Text] [Related]
13. Green self-assembled lactoferrin carboxymethyl cellulose nanogels for synergistic chemo/herbal breast cancer therapy.
Atallah MA; Sallam MA; Abdelmoneem MA; Teleb M; Elkhodairy KA; Bekhit AA; Khafaga AF; Noreldin AE; Elzoghby AO; Khattab SN
Colloids Surf B Biointerfaces; 2022 Sep; 217():112657. PubMed ID: 35803031
[TBL] [Abstract][Full Text] [Related]
14. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
15. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
Zhang BB; Chen XJ; Fan XD; Zhu JJ; Wei YH; Zheng HS; Zheng HY; Wang BH; Piao JG; Li FZ
Acta Pharmacol Sin; 2021 May; 42(5):832-842. PubMed ID: 33824461
[TBL] [Abstract][Full Text] [Related]
16. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study.
Kaur H; Ghosh S; Kumar P; Basu B; Nagpal K
Life Sci; 2021 Nov; 284():119927. PubMed ID: 34492262
[TBL] [Abstract][Full Text] [Related]
17. Enhancing Cellular Uptake and Doxorubicin Delivery of Mesoporous Silica Nanoparticles via Surface Functionalization: Effects of Serum.
Shahabi S; Döscher S; Bollhorst T; Treccani L; Maas M; Dringen R; Rezwan K
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26880-91. PubMed ID: 26562468
[TBL] [Abstract][Full Text] [Related]
18. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
19. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
[TBL] [Abstract][Full Text] [Related]
20. Core-Shell-structured Dendritic Mesoporous Silica Nanoparticles for Combined Photodynamic Therapy and Antibody Delivery.
Abbaraju PL; Yang Y; Yu M; Fu J; Xu C; Yu C
Chem Asian J; 2017 Jul; 12(13):1465-1469. PubMed ID: 28481442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
